PHATHOM PHARMACEUTICALS, INC. Common Stock, Capital Shares Reserved for Future Issuance
PHATHOM PHARMACEUTICALS, INC. (PHAT) had Common Stock, Capital Shares Reserved for Future Issuance of 21.78 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-07-30
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 21.78M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 22.70M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 18.19M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 18.65M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 21.78M shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 22.70M shares 10-Q · filed 2026-04-30 |
| 2025-12-31 | 18.19M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 18.65M shares 10-Q · filed 2025-10-30 |
| 2025-06-30 | 19.31M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 19.78M shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 14.00M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 14.19M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 12.32M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 12.40M shares 10-Q/A · filed 2024-06-14 |
| 2023-12-31 | 9.38M shares 10-K/A · filed 2024-06-14 |
| 2023-09-30 | 10.54M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 10.63M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 10.87M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 8.68M shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 8.78M shares 10-Q/A · filed 2022-11-09 |
| 2022-06-30 | 8.83M shares 10-Q · filed 2022-08-02 |
| 2022-03-31 | 8.83M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 14.65M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 14.89M shares 10-Q · filed 2021-11-08 |
| 2021-06-30 | 14.88M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 14.89M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 13.37M shares 10-K · filed 2021-03-30 |
| 2020-09-30 | 13.42M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 13.42M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 13.42M shares 10-Q · filed 2020-05-12 |
| 2019-12-31 | 11.97M shares 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |